Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Porto
Italo
I
Department of Cardiology, John Radcliffe Hospital, Headley Way, Headington, Oxford, United Kingdom. i.porto@eudoramail.com
Banning
Adrian P
AP
D000328:Adult; D000789:Angina, Unstable / Q000175:diagnosis / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000175:diagnosis / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D018810:Magnetic Resonance Angiography / Q000379:methods; D008297:Male; D017239:Paclitaxel / Q000494:pharmacology*; D018570:Risk Assessment; D020123:Sirolimus / Q000494:pharmacology*; D015607:Stents; D017211:Treatment Failure; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional; D014654:Vascular Patency
D020099:Coated Materials, Biocompatible; D017239:Paclitaxel; D020123:Sirolimus